Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–47. https://doi.org/10.1001/jama.298.17.2038.
Bowe B, Xie Y, Li T, et al. Changes in the US burden of chronic kidney disease from 2002 to 2016: an analysis of the global burden of disease study. JAMA Netw Open. 2018;1(7):e184412. https://doi.org/10.1001/jamanetworkopen.2018.4412.
Ricardo AC, Flessner MF, Eckfeldt JH, et al. Prevalence and correlates of CKD in Hispanics/Latinos in the United States. Clin J Am Soc Nephrol. 2015;10(10):1757–66.
Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension. 2003;42(5):1050–65. https://doi.org/10.1161/01.HYP.0000102971.85504.7c.
Khan S, Amedia CA, Jr. Economic burden of chronic kidney disease. J Eval Clin Pract Jun 2008;14(3):422–434. https://doi.org/10.1111/j.1365-2753.2007.00883.x.
Brück K, Stel VS, Fraser S, et al. Translational research in nephrology: chronic kidney disease prevention and public health. Clin Kidney J. 2015;8(6):647–55. https://doi.org/10.1093/ckj/sfv082.
Han SY, Hong JW, Noh JH, Kim DJ. Association of the estimated 24-h urinary sodium excretion with albuminuria in adult koreans: the 2011 Korea National Health and nutrition examination survey. PLoS One. 2014;9(10):e109073. https://doi.org/10.1371/journal.pone.0109073.
Aaron KJ, Campbell RC, Judd SE, Sanders PW, Muntner P. Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Clin Nutr. 2011;94(4):1071–8. https://doi.org/10.3945/ajcn.111.013094.
Verhave JC, Hillege HL, Burgerhof JG, et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med. 2004;256(4):324–30.
Jones-Burton C, Mishra SI, Fink JC, et al. An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease. Am J Nephrol. 2006;26(3):268–75. https://doi.org/10.1159/000093833.
Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis. 2000;35(6 Suppl 2):S1–140.
James PAOS, Carter BL, Cushman WC, Dennison-Himmelfarb C, et al. 2014 evidence based guideline for the Management of High Blood Pressure in adults report from the panel members appointed to the eighth joint National Committe (JNC8). JAMA. 2014;311(5):507–20.
Verbeke F, Lindley E, Van Bortel L, et al. A European renal best practice (ERBP) position statement on the kidney disease: improving global outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrol Dial Transplant. 2014;29(3):490–6. https://doi.org/10.1093/ndt/gft321.
Thijssen S, Kitzler TM, Levin NW. Salt: its role in chronic kidney disease. J Renal Nutr. 2008;18(1):18–26. https://doi.org/10.1053/j.jrn.2007.10.006.
Middleton JP, Lehrich RW. Prescriptions for dietary sodium in patients with chronic kidney disease: how will this shake out? Kidney Int Sep 2014;86(3):457–459. https://doi.org/10.1038/ki.2014.124.
Levin A, Hemmelgarn B, Culleton B, et al. Guidelines for the management of chronic kidney disease. CMAJ Can Med Assoc J. 2008;179(11):1154–62. https://doi.org/10.1503/cmaj.080351.
Nagata T, Sobajima H, Ohashi N, et al. Association between 24h urinary sodium and potassium excretion and estimated glomerular filtration rate (eGFR) decline or death in patients with diabetes mellitus and eGFR more than 30 ml/min/1.73 m2. PLoS One. 2016;11(5):e0152306.
Elfassy T, Zhang L, Raij L, et al. Results of the CARDIA study suggest that higher dietary potassium may be kidney protective. Kidney Int. 2020;98(1):187–94. https://doi.org/10.1016/j.kint.2020.02.037.
Deriaz D, Guessous I, Vollenweider P, et al. Estimated 24-h urinary sodium and sodium-to-potassium ratio are predictors of kidney function decline in a population-based study. J Hypertens. 2019;37(9):1853–60.
He J, Mills KT, Appel LJ, et al. Urinary sodium and potassium excretion and CKD progression. J Am Soc Nephrol. 2016;27(4):1202–12.
Ogata S, Akashi Y, Sakusabe T, et al. A multiple 24 h urine collection study indicates that kidney function decline is related to urinary sodium and potassium excretion in patients with chronic kidney disease. Kidney Int. 2021;
Yoon C-Y, Noh J, Lee J, et al. High and low sodium intakes are associated with incident chronic kidney disease in patients with normal renal function and hypertension. Kidney Int. 2018;93(4):921–31.
Thomas MC, Moran J, Forsblom C, et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care. 2011;34(4):861–6.
Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol. 2012;23(1):165–73.
Fan L, Tighiouart H, Levey AS, Beck GJ, Sarnak MJ. Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney Int. 2014;86(3):582–8.
McQuarrie EP, Traynor JP, Taylor AH, et al. Association between urinary sodium, creatinine, albumin, and long-term survival in chronic kidney disease. Hypertension. 2014;64(1):111–7.
Smyth A, Dunkler D, Gao P, et al. The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney Int. 2014;86(6):1205–12.
Araki S-i, Haneda M, Koya D, et al. Urinary potassium excretion and renal and cardiovascular complications in patients with type 2 diabetes and normal renal function. Clin J Am Soc Nephrol. 2015;10(12):2152–8.
Ricardo AC, Loop MS, Gonzalez F, et al. Incident chronic kidney disease risk among Hispanics/Latinos in the United States: the Hispanic community health study/study of Latinos (HCHS/SOL). J Am Soc Nephrol. 2020;31(6):1315–24.
Elfassy T, Sotres-Alvarez D, Van Horn L, et al. Daily intake of sodium and potassium among diverse US Hispanics/Latinos, the Hispanic community health study/study of Latinos. Am J Hypertens. 2019;32(9):868–79. https://doi.org/10.1093/ajh/hpz073.
Rodriguez CJAM, Daviglus ML, Isasi CR, Keller C, et al. Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130(7):593–625.
LaVange LM, Kalsbeek WD, Sorlie PD, et al. Sample design and cohort selection in the Hispanic community health study/study of Latinos. Ann Epidemiol. 2010;20(8):642–9.
Siega-Riz AM, Sotres-Alvarez D, Ayala GX, et al. Food-group and nutrient-density intakes by Hispanic and Latino backgrounds in the Hispanic community health study/study of Latinos. Am J Clin Nutr Jun 2014;99(6):1487–1498. https://doi.org/10.3945/ajcn.113.082685.
SAS Institute Inc 2013. SAS/ACCESS® 9.4 Interface to ADABAS: Reference. Cary: SAS Institute Inc.
Henney J, Taylor C, Boon C. Institute of Medicine (US) Committee on Strategies to Reduce Sodium Intake. Washington (DC): National Academies Press (US); 2010. ISBN-13: 978-0-309-14805-4ISBN-13: 978-0-309-14806-1.
Mossavar-Rahmani Y, Sotres-Alvarez D, Wong WW, et al. Applying recovery biomarkers to calibrate self-report measures of sodium and potassium in the Hispanic community health study/study of Latinos. J Hum Hypertens. 2017;31(7):462–73.
Mossavar-Rahmani Y, Shaw PA, Wong WW, et al. Applying recovery biomarkers to calibrate self-report measures of energy and protein in the Hispanic community health study/study of Latinos. Am J Epidemiol. 2015;181(12):996–1007. https://doi.org/10.1093/aje/kwu468.
Baldoni PL, Sotres-Alvarez D, Lumley T, Shaw PA. On the use of regression calibration in a complex sampling design with application to the Hispanic community health study/study of Latinos. Am J Epidemiol. 2021; https://doi.org/10.1093/aje/kwab008.
Thyagarajan B, Howard AG, Durazo-Arvizu R, et al. Analytical and biological variability in biomarker measurement in the Hispanic community health study/study of Latinos. Clin Chim Acta. 2016;463:129–37.
Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–9. https://doi.org/10.1056/NEJMoa1114248.
Peralta CA, Bibbins-Domingo K, Vittinghoff E, et al. <em>APOL1</em> genotype and race differences in incident albuminuria and renal function decline. J Am Soc Nephrol. 2016;27(3):887–93. https://doi.org/10.1681/asn.2015020124.
Arredondo EM, Sotres-Alvarez D, Stoutenberg M, et al. Physical activity levels in U.S. Latino/Hispanic adults: results from the Hispanic community health study/study of Latinos. Am J Prev Med. 2016;50(4):500–8. https://doi.org/10.1016/j.amepre.2015.08.029.
El Assaad MA, Topouchian JA, Darné BM, Asmar RG. Validation of the Omron HEM-907 device for blood pressure measurement. Am J Hypertens. 2002;15(S3):87A.
Schneiderman N, Llabre M, Cowie CC, et al. Prevalence of diabetes among Hispanics/Latinos from diverse backgrounds: the Hispanic community health study/study of Latinos (HCHS/SOL). Diabetes Care. 2014;37(8):2233–9. https://doi.org/10.2337/dc13-2939.
Sorlie PD, Avilés-Santa LM, Wassertheil-Smoller S, et al. Design and implementation of the Hispanic community health study/study of Latinos. Ann Epidemiol. 2010;20(8):629–41.
Selvin S. Statistical analysis of epidemiologic data. USA: Oxford University Press; 2004.
McGuire S. Scientific report of the 2015 dietary guidelines advisory committee. Washington, DC: US Departments of agriculture and health and human services, 2015. Adv Nutr. 2016;7(1):202–4.
Food, drug administration H. food labeling: revision of the nutrition and supplement facts labels. Final rule. Fed Regist. 2016;81(103):33741–999.
Raia JJ Jr, Barone JA, Byerly WG, Lacy CR. Angiotensin-converting enzyme inhibitors: a comparative review. DICP. 1990;24(5):506–25.
Brater DC. Diuretic therapy. N Engl J Med. 1998;339(6):387–95.
Boushey CJ, Coulston AM, Rock CL, Monsen E. Nutrition in the prevention and treatment of disease. Elsevier; 2001.
Perez V, Chang ET. Sodium-to-potassium ratio and blood pressure, hypertension, and related factors. Adv Nutr. 2014;5(6):712–41.
Du S, Neiman A, Batis C, et al. Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China. Am J Clin Nutr. 2014;99(2):334–43.
Cook NR, Obarzanek E, Cutler JA, et al. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the trials of hypertension prevention follow-up study. Arch Intern Med. 2009;169(1):32–40.
Yang Q, Liu T, Kuklina EV, et al. Sodium and potassium intake and mortality among US adults: prospective data from the third National Health and nutrition examination survey. Arch Intern Med. 2011;171(13):1183–91.
Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med. 2001;344(1):3–10.
Rebholz CM, Crews DC, Grams ME, et al. DASH (dietary approaches to stop hypertension) diet and risk of subsequent kidney disease. Am J Kidney Dis. 2016;68(6):853–61.
He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int. 2004;66(6):2454–66.
Pugh D, Gallacher PJ, Dhaun N. Management of Hypertension in chronic kidney disease. Drugs. 2019;79(4):365–79. https://doi.org/10.1007/s40265-019-1064-1.
Castro H, Raij L. Potassium in hypertension and cardiovascular disease. Semin Nephrol. 2013:33(3):277–89.
Lin H, Young DB, Smith MJ Jr. Stimulation of renin release by hyperkalemia in the nonfiltering kidney. Am J Physiol-Renal Physiol. 1991;260(2):F170–6.
Vääräniemi K, Koskela J, Tahvanainen A, et al. Lower glomerular filtration rate is associated with higher systemic vascular resistance in patients without prevalent kidney disease. J Clin Hypertens. 2014;16(10):722–8.
Jin L, Chao L, Chao J. Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2receptor in SHR. Am J Physiol-Renal Physiol. 1999;276(3):F476–84.
Freedman LS, Commins JM, Moler JE, et al. Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for energy and protein intake. Am J Epidemiol. 2014;180(2):172–88. https://doi.org/10.1093/aje/kwu116.
Mercado CI, Cogswell ME, Valderrama AL, et al. Difference between 24-h diet recall and urine excretion for assessing population sodium and potassium intake in adults aged 18–39 y. Am J Clin Nutr. 2015;101(2):376–86.
Curtis CJ, Clapp J, Niederman SA, Ng SW, Angell SY. US food industry Progress during the National Salt Reduction Initiative: 2009-2014. Am J Public Health. 2016;106(10):1815–9. https://doi.org/10.2105/ajph.2016.303397.
Cogswell ME, Zhang Z, Carriquiry AL, et al. Sodium and potassium intakes among US adults: NHANES 2003-2008. Am J Clin Nutr. 2012;96(3):647–57. https://doi.org/10.3945/ajcn.112.034413.
Loftfield E, Yi S, Curtis CJ, Bartley K, Kansagra SM. Potassium and fruit and vegetable intakes in relation to social determinants and access to produce in new York City. Am J Clin Nutr. 2013;98(5):1282–8.